Already on pallitative chemo from jan
Ask Navis about your situation
This answer is general. Get one about your specific case — no signup, answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
This changes the context significantly—you're already receiving palliative chemotherapy, which means your care team has already shifted toward a quality-of-life focused approach.
What This Means:
Palliative chemotherapy (which you've been on since January) is fundamentally different from curative chemotherapy:
- Goal: Manage symptoms and slow disease progression, NOT cure
- Dosing: Often lower doses to minimize side effects
- Frequency: Typically less intensive schedules
- Focus: Balance between disease control and quality of life
This explains several things in your timeline:
- February dose reduction — consistent with palliative approach
- April switch to immunotherapy — still palliative, trying a different strategy
- May hospitalization + radiation — targeted intervention for specific symptoms/problems
- Now considering stopping altogether — natural evolution of palliative care
So What Does "Stopping Treatment Altogether" Mean Now?
You're not choosing between aggressive treatment vs. comfort care—you're already in comfort-focused care. Stopping now would mean:
- No more chemotherapy or immunotherapy infusions
- Continuing palliative/supportive care (symptom management, monitoring)
- Possibly continuing targeted radiation if specific symptoms develop
- Focus entirely on comfort, function, and quality of life
This is a different decision than what I initially understood. Key questions:
-
"Why stop now rather than continue palliative chemo?"
- Is the cancer progressing despite treatment?
- Are side effects outweighing benefits?
- Has disease stabilized enough that monitoring alone is better?
-
"What will change in my day-to-day life if we stop?"
- Fewer hospital visits?
- More energy?
- Different symptom management approach?
-
"How will we monitor for progression?"
- Imaging schedule?
- Blood work?
- Symptom-based monitoring?
-
"What's the plan if disease progresses rapidly?"
- Can we restart treatment?
- Are there other options?
The Real Question:
Since you're already on palliative treatment, stopping likely means:
✅ Stopping active cancer-directed therapy (chemo/immunotherapy) ✅ Continuing palliative care (symptom management, support)
This is actually a reasonable progression in palliative oncology. According to NCCN Guidelines, there's a point where continuing chemotherapy—even at lower doses—may not provide meaningful benefit and can reduce quality of life through:
- Frequent appointments
- Lab work and scans
- Cumulative side effects
- Time spent in treatment rather than living
What Matters Now:
- Understand the reasoning — Why does your team think stopping is the right move NOW?
- Clarify what continues — Palliative care, symptom management, monitoring should all continue
- Know the monitoring plan — How will you know if disease is progressing?
- Prepare for comfort — What's the plan for pain, fatigue, other symptoms?
Resources:
According to the American Cancer Society and NCCN Guidelines, the transition from active treatment to comfort-focused care is:
- A normal part of metastatic cancer management
- Not abandonment—it's a shift in strategy
- Often improves quality of life
- Still includes monitoring and support
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Given that you're already on palliative chemotherapy, this sounds like your team is helping you make a thoughtful transition. The key is understanding why now and ensuring you have a clear plan for what comes next.
Does this better reflect what's actually happening with your care?
Ask Navis about your case
That answer is general. Ask about your specific situation — no signup, answered right here.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Have your records handy? Upload them for a deeper, personalized analysis →
Related Questions
Sarcoma specialist at MDA.
Good—you're at MD Anderson with a sarcoma specialist. That's the right place for LMS. Here's what matters for BostonGene testing with your situation:
New nodules. Two weeks on Generic of VOTRIENT. Having side effects. I also have MGUS. And my original LMS found...
I need to be direct: This is complex, and I can't give you the insight you need through a chat. Here's what I'm seeing: - Leiomyosarcoma LMS — rare
My doctor submitted tissue from lung metastasis (1-2 mm nodules removed last year from two lung lobes). I have...
I need to stop you here because this is important. You've had tissue removed and tested, but you haven't gotten results back? That's a real problem t
Based on my medical records, how relevant is this to my case
I appreciate you sharing your ID removed but I need to be straight with you: I don't actually have your ID removed in front of me right now. To give
What iS aBAT THERAPY for prostate cancer
TL;DR: Bipolar Androgen Therapy BAT is a treatment that cycles testosterone levels up and down to fight prostate cancer that has stopped responding to
What questions should I ask my oncologist about these treatment options
Based on the webinar "Self-Advocacy in the Era of Precision Medicine," here are the specific questions Rome Madison recommends: Testing & Diagnosis
What questions should I ask after a glioblastoma diagnosis
Here are the key questions that will help you understand your situation and treatment options: About Your Specific Tumor - "What grade is my gliobla
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv